首页> 外文期刊>Journal of Clinical Microbiology >Prospective clinical evaluation of Amplicor Mycobacterium tuberculosis PCR test as a screening method in a low-prevalence population.
【24h】

Prospective clinical evaluation of Amplicor Mycobacterium tuberculosis PCR test as a screening method in a low-prevalence population.

机译:在低流行人群中作为一种筛选方法的Amplicor结核分枝杆菌PCR试验的前瞻性临床评估。

获取原文
           

摘要

Of 656 respiratory samples analyzed for Mycobacterium tuberculosis by microscopy, culture, and the Amplicor PCR method, 25 were positive by culture, 12 were positive by microscopy, and 17 were positive by the Amplicor PCR method; 16 samples were Amplicor PCR positive and culture negative. No patient except one with culture-negative, Amplicor PCR-positive samples had clinical indications of tuberculosis. The sensitivity and specificity of the Amplicor PCR compared with those of culture were 68 and 97.4%, respectively. For culture-positive, smear-negative samples, the sensitivity of the Amplicor PCR was 46%.
机译:通过显微镜,培养和Amplicor PCR方法分析的656例呼吸道结核分枝杆菌样本中,培养阳性25例,显微镜阳性12例,Amplicor PCR方法阳性17例; 16个样品均为Amplicor PCR阳性,培养阴性。除一名培养阴性,Amplicor PCR阳性样品的患者外,没有患者有结核的临床指征。与培养相比,Amplicor PCR的敏感性和特异性分别为68%和97.4%。对于培养阳性,涂片阴性的样品,Amplicor PCR的灵敏度为46%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号